Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma
Michael A. Spinner, R Advani, Reid Merryman, Margaret Shipp et al.
Journal
Haematologica
Topics
Phagocytosis and Immune Regulation
article
Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma
Michael A. Spinner, R Advani, Reid Merryman, Margaret Shipp, Cheryl Chang, Austin Yeung, Chandley Silin, Joseph G. Schroers-Martin, Philippe Armand, May Powell
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
Duke University (US), University of California, San Francisco (US), Dana-Farber Cancer Institute (US), Stanford Medicine (US), Stanford University (US)